Grifols SA (GRFS)

Grifols SA (GRFS) Stock Price & Analysis


GRFS Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$5.71 - $13.10
Previous Close$8.85
Average Volume (3M)878.98K
Market Cap
Enterprise Value$7.88B
Total Cash (Recent Filing)€1.96B
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)27.0
Jul 27, 2023
Dividend YieldN/A
Share Statistics
EPS (TTM)0.33
Shares Outstanding261,430,000
10 Day Avg. Volume462,025
30 Day Avg. Volume878,976
Standard Deviation0.09
Financial Highlights & Ratios
Price to Book (P/B)-0.25
Price to Sales (P/S)0.38
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside86.41% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Grifols SA’s price range in the past 12 months?
Grifols SA lowest stock price was $5.71 and its highest was $13.10 in the past 12 months.
    What is Grifols SA’s market cap?
    Currently, no data Available
    When is Grifols SA’s upcoming earnings report date?
    Grifols SA’s upcoming earnings report date is Jul 27, 2023 which is in 49 days.
      How were Grifols SA’s earnings last quarter?
      Grifols SA released its earnings results on May 09, 2023. The company reported $0.044 earnings per share for the quarter, missing the consensus estimate of $0.159 by -$0.115.
        Is Grifols SA overvalued?
        According to Wall Street analysts Grifols SA’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Grifols SA pay dividends?
          Grifols SA pays a Annually dividend of $0.34 which represents an annual dividend yield of N/A. See more information on Grifols SA dividends here
            What is Grifols SA’s EPS estimate?
            Grifols SA’s EPS estimate is $0.19.
              How many shares outstanding does Grifols SA have?
              Grifols SA has 261,425,100 shares outstanding.
                What happened to Grifols SA’s price movement after its last earnings report?
                Grifols SA reported an EPS of $0.044 in its last earnings report, missing expectations of $0.159. Following the earnings report the stock price went up 10.45%.
                  Which hedge fund is a major shareholder of Grifols SA?
                  Among the largest hedge funds holding Grifols SA’s share is Brandes Investment Partners LP. It holds Grifols SA’s shares valued at 76M.


                    Grifols SA Stock Smart Score

                    The Grifols SA stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Grifols SA

                    Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.


                    Top 5 ETFs holding GRFS

                    Market Value
                    Smart Score
                    iShares NASDAQ US Biotechnology UCITS ETF
                    Fidelity Nasdaq Composite Index ETF
                    Invesco Nasdaq Biotechnology ETF
                    Up to five ETFs with an Outperform Smart Score that hold GRFS. The ETFs are listed according to market value of GRFS within the ETF


                    Forecast EPS vs Actual EPS

                    Similar Stocks
                    Price & Change
                    Eli Lilly & Co

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis